Free Biopharma Daily Stock Updates - 03/17/21

$XBI $147.53 +1%

Want to access our searchable database of over 900 catalysts and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

Pipeline Updates

$SAGE +3% 12-month data from ongoing ph 3 SHORELINE study of 30 mg and interim data from 50 mg of Zuranolone for MDD. Additional data from 50 mg cohort expected in late 2021. source


$LTRN +3% Files 7 patent applications on new LP-284 compound based on anticancer properties. source


$IMRA -1% DMCs for Ardent and Forte ph 2b trials of IM-687 for SCD and beta-thal recommended opening the pre-specified higher dose treatment arms. source


$SANA +8% Granted a non-exclusive license to use Fujifilm Cellular Dynamics iPSC platform for the development of commercial cell therapies. source


$AMRN +3% Post-hoc analysis of REDUCE-IT study for strokes in at-risk patients. source


$ESPR +3% Results from ph 2 study of ezetimibe + atorvastatin for LCL-C for hypercholesterolemia, results published in journal Atherosclerosis. source


$ARQT +5% New long term data for ph 2 open-label study of roflumilast 0.3% cream in adults with mild-to-severe chronic plaque psoriasis at Innovations in Dermatology Conference. source


$SRRK -2% US Patent issued with claims that cover both add-on and combo therapy with a myostatin inhibitor and a neuronal corrector therapy for the treatment of SMA. source


$TBIO +3% Announces results from 2nd interim analysis from ongoing ph 1/2 study of MRT5005 in cystic fibrosis. source


$SGMO +3% EMA grants Orphan Drug Designation for BIVV003 for sickle cell disease. source


Financial Updates

$SLDB +4% Offering. source


$PHAS -6% Offering. source

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE